Summit Therapeutics Inc. Annual Operating Lease, Payments in USD from 2017 to 2024

Taxonomy & unit: us-gaap: USD
Description: Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary: Summit Therapeutics Inc. annual/quarterly Operating Lease, Payments history and growth rate from 2017 to 2024.
Summit Therapeutics Inc. Operating Lease, Payments for the quarter ending March 31, 2023 was $367K, a 23.6% increase year-over-year.
Summit Therapeutics Inc. annual Operating Lease, Payments for 2024 was $2.57M, a 16.3% increase from 2023.
Summit Therapeutics Inc. annual Operating Lease, Payments for 2023 was $2.21M, a 102% increase from 2022.
Summit Therapeutics Inc. annual Operating Lease, Payments for 2022 was $1.09M, a 4.9% increase from 2021.

Operating Lease, Payments, Annual (USD)

Operating Lease, Payments, YoY Annual Growth (%)

Period	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
2024	$2.57M	+$360K	+16.3%	Jan 1, 2024	Dec 31, 2024	10-K	2025-02-24
2023	$2.21M	+$1.12M	+102%	Jan 1, 2023	Dec 31, 2023	10-K	2025-02-24
2022	$1.09M	+$51K	+4.9%	Jan 1, 2022	Dec 31, 2022	10-K	2024-02-20
2021	$1.04M	+$553K	+113%	Jan 1, 2021	Dec 31, 2021	10-K	2023-03-09
2020	$488K	+$53K	+12.2%	Jan 1, 2020	Dec 31, 2020	10-K	2021-03-31
2019	$435K	+$66K	+17.9%	Feb 1, 2019	Dec 31, 2019	10-K	2021-03-31
2018	$369K	+$187K	+103%	Feb 1, 2018	Jan 31, 2019	10-K	2021-03-31
2017	$182K			Feb 1, 2017	Jan 31, 2018	8-K	2020-09-29

Showing 1 to 8 of 8 entries

* An asterisk sign (*) next to the value indicates that the value is likely invalid.